Annual report

Period2023-12-01 → 2024-11-30
Filed2025-02-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 151
MetricValuePeriodScopeSource row
Revenue¥58.0bn2023-12-01 → 2024-11-30Cons.Net sales
Revenue¥52.0bn2022-12-01 → 2023-11-30Cons.Net sales
Revenue¥49.6bn2021-12-01 → 2022-11-30dCons.Net sales (5-year summary)
Revenue¥72.3bn2020-12-01 → 2021-11-30dCons.Net sales (5-year summary)
Revenue¥65.3bn2019-12-01 → 2020-11-30dCons.Net sales (5-year summary)
Operating income¥2.8bn2023-12-01 → 2024-11-30Cons.Operating income
Operating income¥1.1bn2022-12-01 → 2023-11-30Cons.Operating income
Ordinary income¥2.8bn2023-12-01 → 2024-11-30Cons.Ordinary income
Ordinary income¥1.4bn2022-12-01 → 2023-11-30Cons.Ordinary income
Ordinary income¥887m2021-12-01 → 2022-11-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2020-12-01 → 2021-11-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥2.0bn2019-12-01 → 2020-11-30dCons.Ordinary income loss (5-year summary)
Profit before tax−¥1.5bn2023-12-01 → 2024-11-30Cons.Income before income taxes
Profit before tax¥1.6bn2022-12-01 → 2023-11-30Cons.Income before income taxes
Net income (owners)−¥2.5bn2023-12-01 → 2024-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-12-01 → 2023-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥580m2021-12-01 → 2022-11-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.7bn2020-12-01 → 2021-11-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.0bn2019-12-01 → 2020-11-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income−¥2.5bn2023-12-01 → 2024-11-30Cons.Profit loss
Net income¥1.2bn2022-12-01 → 2023-11-30Cons.Profit loss
Total assets¥64.6bnat 2024-11-30Cons.Assets
Total assets¥67.3bnat 2023-11-30Cons.Assets
Total assets¥63.6bnat 2022-11-30dCons.Total assets (5-year summary)
Total assets¥63.6bnat 2021-11-30dCons.Total assets (5-year summary)
Total assets¥54.3bnat 2020-11-30dCons.Total assets (5-year summary)
Total liabilities¥39.3bnat 2024-11-30Cons.Liabilities
Total liabilities¥38.7bnat 2023-11-30Cons.Liabilities
Net assets / equity¥25.3bnat 2024-11-30Cons.Net assets
Net assets / equity¥28.6bnat 2023-11-30Cons.Net assets
Net assets / equity¥27.1bnat 2022-11-30dCons.Net assets
Net assets / equity¥27.0bnat 2021-11-30dCons.Net assets (5-year summary)
Net assets / equity¥21.7bnat 2020-11-30dCons.Net assets (5-year summary)
Cash and deposits¥6.1bnat 2024-11-30Cons.Cash and deposits
Cash and deposits¥6.9bnat 2023-11-30Cons.Cash and deposits
Cash & equivalents¥6.0bnat 2024-11-30Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2023-11-30Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2022-11-30dCons.Cash and cash equivalents
Cash & equivalents¥10.8bnat 2021-11-30dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥7.4bnat 2020-11-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥4.8bn2023-12-01 → 2024-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.6bn2022-12-01 → 2023-11-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥742m2021-12-01 → 2022-11-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.3bn2020-12-01 → 2021-11-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥4.1bn2019-12-01 → 2020-11-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥2.9bn2023-12-01 → 2024-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.8bn2022-12-01 → 2023-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.2bn2021-12-01 → 2022-11-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.4bn2020-12-01 → 2021-11-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥8.3bn2019-12-01 → 2020-11-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥2.7bn2023-12-01 → 2024-11-30Cons.Net cash provided by used in financing activities
Financing cash flow¥1.1bn2022-12-01 → 2023-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.1bn2021-12-01 → 2022-11-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥6.4bn2020-12-01 → 2021-11-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥6.8bn2019-12-01 → 2020-11-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-63.182023-12-01 → 2024-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.472022-12-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.562021-12-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.862020-12-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.332019-12-01 → 2020-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥46.632020-12-01 → 2021-11-30dCons.Diluted earnings per share (5-year summary)
Net assets per share¥625.15at 2024-11-30Cons.Net assets per share (5-year summary)
Net assets per share¥719.53at 2023-11-30Cons.Net assets per share (5-year summary)
Net assets per share¥685.24at 2022-11-30dCons.Net assets per share (5-year summary)
Net assets per share¥677.09at 2021-11-30dCons.Net assets per share (5-year summary)
Net assets per share¥656.54at 2020-11-30dCons.Net assets per share (5-year summary)
Equity ratio39.0%at 2024-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio42.3%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio42.5%at 2022-11-30dCons.Equity to asset ratio (5-year summary)
Equity ratio42.5%at 2021-11-30dCons.Equity to asset ratio (5-year summary)
Equity ratio39.9%at 2020-11-30dCons.Equity to asset ratio (5-year summary)
ROE-9.4%2023-12-01 → 2024-11-30Cons.Rate of return on equity (5-year summary)
ROE4.2%2022-12-01 → 2023-11-30Cons.Rate of return on equity (5-year summary)
ROE2.1%2021-12-01 → 2022-11-30dCons.Rate of return on equity (5-year summary)
ROE7.1%2020-12-01 → 2021-11-30dCons.Rate of return on equity (5-year summary)
ROE9.4%2019-12-01 → 2020-11-30dCons.Rate of return on equity (5-year summary)
Employees1,420at 2024-11-30Cons.Number of employees
Employees1,404at 2023-11-30Cons.Number of employees
Employees1,383at 2022-11-30dCons.Number of employees
Employees1,368at 2021-11-30dCons.Number of employees
Employees1,295at 2020-11-30dCons.Number of employees
Revenue¥2.9bn2023-12-01 → 2024-11-30StandaloneOperating revenue1
Revenue¥2.8bn2022-12-01 → 2023-11-30StandaloneOperating revenue1
Revenue¥2.8bn2021-12-01 → 2022-11-30dStandaloneOperating revenue1 (5-year summary)
Revenue¥23.0bn2020-12-01 → 2021-11-30dStandaloneNet sales (5-year summary)
Revenue¥1.3bn2020-12-01 → 2021-11-30dStandaloneOperating revenue1 (5-year summary)
Revenue¥47.2bn2019-12-01 → 2020-11-30dStandaloneNet sales (5-year summary)
Operating income¥85m2023-12-01 → 2024-11-30StandaloneOperating income
Operating income¥259m2022-12-01 → 2023-11-30StandaloneOperating income
Ordinary income−¥29m2023-12-01 → 2024-11-30StandaloneOrdinary income
Ordinary income¥210m2022-12-01 → 2023-11-30StandaloneOrdinary income
Ordinary income¥290m2021-12-01 → 2022-11-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥304m2020-12-01 → 2021-11-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥290m2019-12-01 → 2020-11-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥215m2023-12-01 → 2024-11-30StandaloneIncome before income taxes
Profit before tax¥1.0bn2022-12-01 → 2023-11-30StandaloneIncome before income taxes
Net income¥93m2023-12-01 → 2024-11-30StandaloneProfit loss
Net income¥702m2022-12-01 → 2023-11-30StandaloneProfit loss
Net income¥831m2021-12-01 → 2022-11-30dStandaloneNet income loss (5-year summary)
Net income¥788m2020-12-01 → 2021-11-30dStandaloneNet income loss (5-year summary)
Net income¥255m2019-12-01 → 2020-11-30dStandaloneNet income loss (5-year summary)
Total assets¥31.0bnat 2024-11-30StandaloneAssets
Total assets¥32.7bnat 2023-11-30StandaloneAssets
Total assets¥30.1bnat 2022-11-30dStandaloneTotal assets (5-year summary)
Total assets¥30.2bnat 2021-11-30dStandaloneTotal assets (5-year summary)
Total assets¥39.3bnat 2020-11-30dStandaloneTotal assets (5-year summary)
Total liabilities¥17.3bnat 2024-11-30StandaloneLiabilities
Total liabilities¥18.0bnat 2023-11-30StandaloneLiabilities
Net assets / equity¥13.7bnat 2024-11-30StandaloneNet assets
Net assets / equity¥14.6bnat 2023-11-30StandaloneNet assets
Net assets / equity¥13.9bnat 2022-11-30dStandaloneNet assets
Net assets / equity¥14.0bnat 2021-11-30dStandaloneNet assets (5-year summary)
Net assets / equity¥12.9bnat 2020-11-30dStandaloneNet assets (5-year summary)
Cash and deposits¥569mat 2024-11-30StandaloneCash and deposits
Cash and deposits¥758mat 2023-11-30StandaloneCash and deposits
EPS (basic)¥2.322023-12-01 → 2024-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥17.792022-12-01 → 2023-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥20.882021-12-01 → 2022-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥21.272020-12-01 → 2021-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥7.752019-12-01 → 2020-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥21.162020-12-01 → 2021-11-30dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥182023-12-01 → 2024-11-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥182022-12-01 → 2023-11-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥182021-12-01 → 2022-11-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥182020-12-01 → 2021-11-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥162019-12-01 → 2020-11-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥340.64at 2024-11-30StandaloneNet assets per share (5-year summary)
Net assets per share¥370.38at 2023-11-30StandaloneNet assets per share (5-year summary)
Net assets per share¥352.82at 2022-11-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥350.47at 2021-11-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥392.26at 2020-11-30dStandaloneNet assets per share (5-year summary)
Equity ratio44.2%at 2024-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.8%at 2023-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio46.2%at 2022-11-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio46.3%at 2021-11-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio32.9%at 2020-11-30dStandaloneEquity to asset ratio (5-year summary)
ROE0.7%2023-12-01 → 2024-11-30StandaloneRate of return on equity (5-year summary)
ROE4.9%2022-12-01 → 2023-11-30StandaloneRate of return on equity (5-year summary)
ROE6.0%2021-12-01 → 2022-11-30dStandaloneRate of return on equity (5-year summary)
ROE5.9%2020-12-01 → 2021-11-30dStandaloneRate of return on equity (5-year summary)
ROE1.9%2019-12-01 → 2020-11-30dStandaloneRate of return on equity (5-year summary)
Shares issued40,982,832at 2024-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued40,884,504at 2023-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued40,772,366at 2022-11-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued40,630,087at 2021-11-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued34,729,839at 2020-11-30dStandaloneTotal number of issued shares (5-year summary)
Employees95at 2024-11-30StandaloneNumber of employees
Employees93at 2023-11-30StandaloneNumber of employees
Employees105at 2022-11-30dStandaloneNumber of employees
Employees109at 2021-11-30dStandaloneNumber of employees
Employees323at 2020-11-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 84
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2023-12-01 → 2024-11-30¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2024-11-3011 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-12-01 → 2024-11-30¥46m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-12-01 → 2024-11-30¥38m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-12-01 → 2024-11-30¥8m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-12-01 → 2024-11-30−¥137m
Reconciling Itemsreconcilingdepreciation2023-12-01 → 2024-11-30¥427m
Reconciling Itemsreconcilingrevenue2023-12-01 → 2024-11-30−¥1.4bn
Reconciling Itemsreconcilingrevenue intersegment2023-12-01 → 2024-11-30−¥1.4bn
Reconciling Itemsreconcilingsegment profit2023-12-01 → 2024-11-30−¥61m
Fine Chemicalsreportable segmentdepreciation2023-12-01 → 2024-11-30¥1.0bn
Fine Chemicalsreportable segmentemployeesat 2024-11-30546 pure
Fine Chemicalsreportable segmentrevenue2023-12-01 → 2024-11-30¥22.0bn
Fine Chemicalsreportable segmentrevenue external2023-12-01 → 2024-11-30¥21.1bn
Fine Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-11-30¥912m
Fine Chemicalsreportable segmentsegment profit2023-12-01 → 2024-11-30¥243m
Health And Beauty Care Foodreportable segmentdepreciation2023-12-01 → 2024-11-30¥49m
Health And Beauty Care Foodreportable segmentemployeesat 2024-11-30229 pure
Health And Beauty Care Foodreportable segmentrevenue2023-12-01 → 2024-11-30¥15.3bn
Health And Beauty Care Foodreportable segmentrevenue external2023-12-01 → 2024-11-30¥15.2bn
Health And Beauty Care Foodreportable segmentrevenue intersegment2023-12-01 → 2024-11-30¥94m
Health And Beauty Care Foodreportable segmentsegment profit2023-12-01 → 2024-11-30¥742m
Industrial Chemicalsreportable segmentdepreciation2023-12-01 → 2024-11-30¥323m
Industrial Chemicalsreportable segmentemployeesat 2024-11-30325 pure
Industrial Chemicalsreportable segmentrevenue2023-12-01 → 2024-11-30¥10.3bn
Industrial Chemicalsreportable segmentrevenue external2023-12-01 → 2024-11-30¥10.2bn
Industrial Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-11-30¥70m
Industrial Chemicalsreportable segmentsegment profit2023-12-01 → 2024-11-30¥713m
Medicalreportable segmentdepreciation2023-12-01 → 2024-11-30¥211m
Medicalreportable segmentemployeesat 2024-11-30205 pure
Medicalreportable segmentrevenue2023-12-01 → 2024-11-30¥11.8bn
Medicalreportable segmentrevenue external2023-12-01 → 2024-11-30¥11.5bn
Medicalreportable segmentrevenue intersegment2023-12-01 → 2024-11-30¥316m
Medicalreportable segmentsegment profit2023-12-01 → 2024-11-30¥1.3bn
—segment totaldepreciation2023-12-01 → 2024-11-30¥1.6bn
—segment totalemployeesat 2024-11-301305 pure
—segment totalrevenue2023-12-01 → 2024-11-30¥59.3bn
—segment totalrevenue external2023-12-01 → 2024-11-30¥58.0bn
—segment totalrevenue intersegment2023-12-01 → 2024-11-30¥1.4bn
—segment totalsegment profit2023-12-01 → 2024-11-30¥3.0bn
Total Of Reportable Segments And Otherssegment totaldepreciation2023-12-01 → 2024-11-30¥1.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-11-30¥59.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-11-30¥58.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-12-01 → 2024-11-30¥1.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-11-30¥2.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2022-12-01 → 2023-11-30¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-12-01 → 2023-11-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-12-01 → 2023-11-30¥17m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-12-01 → 2023-11-30¥2m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-12-01 → 2023-11-30−¥104m
Reconciling Itemsreconcilingdepreciation2022-12-01 → 2023-11-30¥444m
Reconciling Itemsreconcilingrevenue2022-12-01 → 2023-11-30−¥1.5bn
Reconciling Itemsreconcilingrevenue intersegment2022-12-01 → 2023-11-30−¥1.5bn
Reconciling Itemsreconcilingsegment profit2022-12-01 → 2023-11-30¥99m
Fine Chemicalsreportable segmentdepreciation2022-12-01 → 2023-11-30¥874m
Fine Chemicalsreportable segmentrevenue2022-12-01 → 2023-11-30¥20.9bn
Fine Chemicalsreportable segmentrevenue external2022-12-01 → 2023-11-30¥19.9bn
Fine Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-11-30¥1.0bn
Fine Chemicalsreportable segmentsegment profit2022-12-01 → 2023-11-30¥214m
Health And Beauty Care Foodreportable segmentdepreciation2022-12-01 → 2023-11-30¥69m
Health And Beauty Care Foodreportable segmentrevenue2022-12-01 → 2023-11-30¥14.1bn
Health And Beauty Care Foodreportable segmentrevenue external2022-12-01 → 2023-11-30¥14.1bn
Health And Beauty Care Foodreportable segmentrevenue intersegment2022-12-01 → 2023-11-30¥84m
Health And Beauty Care Foodreportable segmentsegment profit2022-12-01 → 2023-11-30¥325m
Industrial Chemicalsreportable segmentdepreciation2022-12-01 → 2023-11-30¥336m
Industrial Chemicalsreportable segmentrevenue2022-12-01 → 2023-11-30¥8.7bn
Industrial Chemicalsreportable segmentrevenue external2022-12-01 → 2023-11-30¥8.6bn
Industrial Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-11-30¥66m
Industrial Chemicalsreportable segmentsegment profit2022-12-01 → 2023-11-30¥74m
Medicalreportable segmentdepreciation2022-12-01 → 2023-11-30¥168m
Medicalreportable segmentrevenue2022-12-01 → 2023-11-30¥9.8bn
Medicalreportable segmentrevenue external2022-12-01 → 2023-11-30¥9.5bn
Medicalreportable segmentrevenue intersegment2022-12-01 → 2023-11-30¥362m
Medicalreportable segmentsegment profit2022-12-01 → 2023-11-30¥520m
—segment totaldepreciation2022-12-01 → 2023-11-30¥1.4bn
—segment totalrevenue2022-12-01 → 2023-11-30¥53.5bn
—segment totalrevenue external2022-12-01 → 2023-11-30¥52.0bn
—segment totalrevenue intersegment2022-12-01 → 2023-11-30¥1.5bn
—segment totalsegment profit2022-12-01 → 2023-11-30¥1.1bn
Total Of Reportable Segments And Otherssegment totaldepreciation2022-12-01 → 2023-11-30¥1.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-11-30¥53.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-11-30¥52.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-12-01 → 2023-11-30¥1.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-11-30¥1.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,924
ItemContextValueUnit
Increase decrease in accrued expenses ope cfCurrentYearDuration629404000JPY
Increase decrease in accrued consumption taxes ope cfPrior1YearDuration29555000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYearDuration207085000JPY
Other net ope cfPrior1YearDuration311569000JPY
Other net ope cfCurrentYearDuration-220330000JPY
Subtotal ope cfPrior1YearDuration2994066000JPY
Subtotal ope cfCurrentYearDuration5733535000JPY
Interest and dividends income received ope cf inv cfPrior1YearDuration63261000JPY
Interest and dividends income received ope cf inv cfCurrentYearDuration63327000JPY
Interest expenses paid ope cf fin cfPrior1YearDuration-60148000JPY
Interest expenses paid ope cf fin cfCurrentYearDuration-74002000JPY
Payments for directors retirement benefits ope cfPrior1YearDuration-690000JPY
Payments for directors retirement benefits ope cfCurrentYearDuration-JPY
Income taxes paid ope cfPrior1YearDuration-1443669000JPY
Income taxes paid ope cfCurrentYearDuration-894109000JPY
Income taxes refund ope cfPrior1YearDuration91106000JPY
Income taxes refund ope cfCurrentYearDuration19555000JPY
Net cash provided by used in operating activitiesPrior1YearDuration1643927000JPY
Net cash provided by used in operating activitiesCurrentYearDuration4848306000JPY
Purchase of property plant and equipment inv cfPrior1YearDuration-3820827000JPY
Purchase of property plant and equipment inv cfCurrentYearDuration-2840559000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YearDuration1649690000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYearDuration1556000JPY
Purchase of intangible assets inv cfPrior1YearDuration-344199000JPY
Purchase of intangible assets inv cfCurrentYearDuration-357289000JPY
Purchase of investment securities inv cfPrior1YearDuration-249260000JPY
Purchase of investment securities inv cfCurrentYearDuration-153198000JPY
Proceeds from sales of investment securities inv cfPrior1YearDuration68180000JPY
Proceeds from sales of investment securities inv cfCurrentYearDuration480137000JPY
Subsidies received inv cfPrior1YearDuration30066000JPY
Subsidies received inv cfCurrentYearDuration14244000JPY
Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YearDuration-75937000JPY
Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYearDuration-JPY
Proceeds from maturity of insurance funds inv cfPrior1YearDuration27804000JPY
Proceeds from maturity of insurance funds inv cfCurrentYearDuration8556000JPY
Other net inv cfPrior1YearDuration-120871000JPY
Other net inv cfCurrentYearDuration-91109000JPY
Net cash provided by used in investment activitiesPrior1YearDuration-2835354000JPY
Net cash provided by used in investment activitiesCurrentYearDuration-2937662000JPY
Net increase decrease in short term loans payable fin cfPrior1YearDuration1989000000JPY
Net increase decrease in short term loans payable fin cfCurrentYearDuration-718000000JPY
Proceeds from long term loans payable fin cfPrior1YearDuration1000000000JPY
Proceeds from long term loans payable fin cfCurrentYearDuration-JPY
Repayment of long term loans payable fin cfPrior1YearDuration-1197984000JPY
Repayment of long term loans payable fin cfCurrentYearDuration-1197984000JPY
Repayments of finance lease obligations fin cfPrior1YearDuration-105083000JPY
Repayments of finance lease obligations fin cfCurrentYearDuration-77339000JPY
Proceeds from share issuance to non controlling shareholders fin cfPrior1YearDuration110900000JPY
Proceeds from share issuance to non controlling shareholders fin cfCurrentYearDuration76300000JPY
Cash dividends paid fin cfPrior1YearDuration-719055000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-11-30pass rounding
balance sheet identityconsolidated 2024-11-30pass
balance sheet identitynon_consolidated 2023-11-30pass
balance sheet identitynon_consolidated 2024-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsconsolidated 2024-11-30pass
statement vs summary · net assetsnon_consolidated 2022-11-30pass
statement vs summary · net assetsnon_consolidated 2023-11-30pass
statement vs summary · net assetsnon_consolidated 2024-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-11-30pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-11-30pass
statement vs summary · operating cash flowconsolidated 2022-12-01/2023-11-30pass
statement vs summary · operating cash flowconsolidated 2023-12-01/2024-11-30pass
statement vs summary · revenueconsolidated 2022-12-01/2023-11-30pass
statement vs summary · revenueconsolidated 2023-12-01/2024-11-30pass
statement vs summary · revenuenon_consolidated 2022-12-01/2023-11-30pass
statement vs summary · revenuenon_consolidated 2023-12-01/2024-11-30pass
statement vs summary · total assetsconsolidated 2023-11-30pass
statement vs summary · total assetsconsolidated 2024-11-30pass
statement vs summary · total assetsnon_consolidated 2023-11-30pass
statement vs summary · total assetsnon_consolidated 2024-11-30pass